HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role of 5-HT7 receptor antagonism in the amelioration of MK-801-induced learning and memory deficits by the novel atypical antipsychotic drug lurasidone.

Abstract
Lurasidone is a novel atypical antipsychotic with high affinity for dopamine D2, serotonin 5-HT7 and 5-HT2A receptors. We previously reported that lurasidone and the selective 5-HT7 receptor antagonist, SB-656104-A improved learning and memory deficits induced by MK-801, an N-methyl-d-aspartate (NMDA) receptor antagonist, in the rat passive avoidance test. In this study, we first examined the role of the 5-HT7 receptor antagonistic activity of lurasidone in its pro-cognitive effect to ameliorate MK-801-induced deficits in the rat passive avoidance test. The 5-HT7 receptor agonist, AS19, (2S)-(+)-5-(1,3,5-trimethylpyrazol-4-yl)-2-(dimethylamino) tetralin, (3 mg/kg, s.c.) completely blocked the attenuating effects of lurasidone (3 mg/kg, p.o.), highlighting the importance of 5-HT7 receptor antagonism in the pro-cognitive effect of lurasidone. AS19 (3 mg/kg, s.c.) also blocked the ameliorating effect of SB-656104-A (10 mg/kg, i.p.) in the same experimental paradigm. To further extend our observation, we next tested whether 5-HT7 receptor antagonism still led to the amelioration of MK-801-induced deficits when combined with D2 and 5-HT2A receptor antagonists, and found that SB-656104-A (10 mg/kg, i.p.) significantly ameliorated MK-801-induced deficits even in the presence of the D2 receptor antagonist raclopride (0.1 mg/kg, s.c.) and 5-HT2A receptor antagonist ketanserin (1 mg/kg, s.c.). Taken together, these results suggest that the 5-HT7 receptor antagonistic activity of lurasidone plays an important role in its effectiveness against MK-801-induced deficits, and may contribute to its pharmacological actions in patients with schizophrenia.
AuthorsTomoko Horisawa, Hiroyuki Nishikawa, Satoko Toma, Atsushi Ikeda, Masakuni Horiguchi, Michiko Ono, Takeo Ishiyama, Mutsuo Taiji
JournalBehavioural brain research (Behav Brain Res) Vol. 244 Pg. 66-9 (May 01 2013) ISSN: 1872-7549 [Electronic] Netherlands
PMID23376699 (Publication Type: Journal Article)
CopyrightCopyright © 2013 Elsevier B.V. All rights reserved.
Chemical References
  • AS 19 compound
  • Antipsychotic Agents
  • Dopamine Antagonists
  • Isoindoles
  • Phenols
  • Pyrazoles
  • Pyrrolidines
  • Receptors, Serotonin
  • SB-656104-A
  • Serotonin Antagonists
  • Serotonin Receptor Agonists
  • Tetrahydronaphthalenes
  • Thiazoles
  • serotonin 7 receptor
  • Raclopride
  • Dizocilpine Maleate
  • Ketanserin
  • Lurasidone Hydrochloride
Topics
  • Animals
  • Antipsychotic Agents (antagonists & inhibitors, pharmacology)
  • Avoidance Learning (drug effects)
  • Dizocilpine Maleate (antagonists & inhibitors, pharmacology)
  • Dopamine Antagonists (pharmacology)
  • Isoindoles (antagonists & inhibitors, pharmacology)
  • Ketanserin (pharmacology)
  • Lurasidone Hydrochloride
  • Male
  • Memory (drug effects)
  • Phenols (pharmacology)
  • Pyrazoles (pharmacology)
  • Pyrrolidines (pharmacology)
  • Raclopride (pharmacology)
  • Rats
  • Receptors, Serotonin (drug effects)
  • Serotonin Antagonists (pharmacology)
  • Serotonin Receptor Agonists (pharmacology)
  • Tetrahydronaphthalenes (pharmacology)
  • Thiazoles (antagonists & inhibitors, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: